Mar Mallo

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

Journal: Blood advances
Published: April 08, 2026

A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing.

A Murine Model of Glioblastoma Initiating Cells and Human Brain Organoid Xenograft for Photodynamic Therapy Testing.

Journal: International journal of molecular sciences
Published: July 13, 2025

Integrated cytogenetic and genomic profiling of the MDS-L cell line.

Integrated cytogenetic and genomic profiling of the MDS-L cell line.

Journal: Molecular cytogenetics
Published: April 25, 2025

The multiomics blueprint of the individual with the most extreme lifespan.

The multiomics blueprint of the individual with the most extreme lifespan.

Journal: Cell reports. Medicine
Published: April 02, 2025

Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma.

Optical Genome Mapping (OGM): Validation and Clinical Utility in the Cytogenetic Diagnosis of Multiple Myeloma.

Journal: American journal of hematology
Published: March 24, 2025

Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping.

Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping.

Journal: American journal of hematology
Published: March 13, 2025

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Multikinase Treatment of Glioblastoma: Evaluating the Rationale for Regorafenib.

Journal: Cancers
Published: December 05, 2024

The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T Mutation.

Journal: Cancers
Published: January 16, 2024

A framework for the clinical implementation of optical genome mapping in hematologic malignancies.

A framework for the clinical implementation of optical genome mapping in hematologic malignancies.

Journal: American journal of hematology
Published: August 12, 2023

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype.

Regions of homozygosity confer a worse prognostic impact in myelodysplastic syndrome with normal karyotype.

Journal: EJHaem
Published: January 10, 2023

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment.

Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment.

Journal: Cancers
Published: September 30, 2022

In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.

In silico validation of RNA-Seq results can identify gene fusions with oncogenic potential in glioblastoma.

Journal: Scientific reports
Published: June 01, 2022
Showing 1-12 of 48

Last Updated: 09/26/2026